Innovating and scaling innovation can be viewed as two separate disciplines. Each usually has its own set of challenges and success factors. To be able to scale innovations effectively, it is important to explore collaborations across various stakeholder groups, especially for corporates and startups, leveraging each other’s strengths and assets.
In this panel discussion, we bring together corporate innovators from Akzo Nobel (Oscar Wezenbeek) and Philips (Diederik Zeven) as well as startup founders Abhishek Gupta, CEO and Founder of Movel AI and Dr Philip Wong, Interim CEO and Chief Medical Officer of Web Biotechnology from Singapore. They are all active in the innovation space and are working to scale innovation in their respective industries.
The speakers will discuss their efforts in driving successful innovation programmes and pilot projects, and their perspectives on how to effectively collaborate with partners to adopt innovative solutions.
10:00 am – 10:05 am: Opening remarks by SGInnovate and ADB-DutchCham
10:05 am – 11:00 am: Panel Discussion and Q&A
Should you wish to join you can register here via the website of SG Innovate.
Diederik Zeven, Senior Vice President & General Manager at Philips
In February 2015 Diederik continued his long and successful career within Philips with a move to Singapore to head up the Healthcare Division for ASEAN Pacific. Having originally joined the organization in Hong Kong in 1994, where he worked on largescale healthcare projects in China and India, this was a welcome return to the region.
Prior to this current role Diederik was General Manager, responsible for Philips Healthcare business in the Middle East and Turkey, based in Dubai, UAE for 7 years and Istanbul, Turkey for 2 years. Diederik was strongly committed to ensuring that Philips Healthcare responded to the local needs of its customers in the Middle East and Turkey with locally relevant solutions and services. He oversaw the signing of a joint venture between Philips Healthcare and Al Faisaliah Medical Systems to expand the company’s healthcare equipment and solutions service offering in the Kingdom of Saudi Arabia.
Oscar Wezenbeek, Managing Director Decorative Paints South Asia and South East Asia (SESA) at Akzo Nobel
Oscar Wezenbeek is AkzoNobel’s Managing Director for the South Asia – and South East Asia Decorative (Paints SESA) business unit reporting directly to the Executive Committee of AkzoNobel. His key responsibilities include growing the business by improving competitiveness and expanding the company’s leading market positions.
Having joined the company in 1989, Oscar has since held various management positions within AkzoNobel. Before managing the Decorative Paints business in SESA, he was the global MD for Marine, Protective & Yacht Coatings (MPY). Prior to his work in MPY he held various management positions in the Powder – and Automotive – and Aerospace Coatings units of AkzoNobel on a regional – and global level.
During his career, he has lived and worked in the Netherlands, Spain, Sweden and is currently stationed in Singapore.
Abhishek Gupta, CEO and Founder, Movel AI
Abhishek is the founder and CEO of Movel AI. Movel AI is a deep tech company providing AI-based navigation system to hardware robotic companies. Having raised more than 2M SGD, Movel AI is making robot adoption easier through their flagship product seiriOS.
He was the leading researcher at SUTD, where he worked on self-driving bicycles and solar-powered robots. Before starting Movel AI, he founded EdgeBotix, a hardware robotics company, where he designed and sold hundreds of educational robots to a Singapore University.
Dr Philip Wong, Interim CEO and Chief Medical Officer, Web Biotechnology
Dr Philip Wong is a Clinician Innovator & Senior Consultant Interventional Cardiologist at the National Heart Center Singapore. An interventional cardiologist by training. He has seen greater than 20,000 outpatients visits and implanted greater than 5,000 coronary stents in his career as a physician.
Dr Wong has research Interest in Medical Devices and Digital Health. He previously held positions as adjunct Professor, school of materials science, NTU, where he taught the development of medical devices. He is currently Associate Professor, Duke-NUS and continuous to enjoy sharing clinical experience, innovation and research ideas with medical students.
Dr Wong is the founder of WEB Biotechnology, a Singaporean based company that created and markets the Spyder ECG, a cloud-based continuous ECG monitoring Ecosystem. This device has received Medical CE certification and is currently available in the EU and many countries in Asia. https://www.spyderecg.com/.
He is also the Founder & CEO/Chief Technical Officer of Innoheart Pte Ltd, a 12,000 sq foot Preclinical Contract Research Organisation for evaluating implantable medical devices. Dr Wong has been Study PI in over 160 large animal studies, including several GLP studies for regulatory approvals.
The session will be moderated by Kellie Chan, Senior Manager – Venture Investing, SGInnovate.